Vertex completes $10.0 billion acquisition of Crinetics PharmaceuticalsSep 1M&ACrinetics Pharmaceuticals, Inc
Crinetics reports Q2 2026 results alongside pending $10 billion Vertex acquisitionAug 3Quarterly updateCrinetics Pharmaceuticals, Incpaltusotine
Crinetics discloses non-compete deals with executives tied to Vertex mergerJul 10PartnershipCrinetics Pharmaceuticals, Inc
Vertex to acquire Crinetics for $85 a share in $10 billion dealJul 6M&ACrinetics Pharmaceuticals, Incpaltusotine
Sign inSign in